Dr. Lulu Zhang, MD

Dr. Zhang practices at Pacific Cancer Care in Monterey, California.

Dr. Zhang's NPI, 1396003562, was assigned on April 25, 2012. Dr. Zhang graduated from Peking Union Medical College in 2008. Dr. Zhang's New York license number on file is 294828.

Dr. Zhang's primary practice is Pacific Cancer Care, at 5 Harris Ct, Monterey, CA 93940 in Monterey County. The practice phone is (831) 375-4105.

Dr. Zhang's primary practice is Pacific Cancer Care in Monterey, California. Dr. Zhang is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Pacific Cancer Care. Dmand AI also links Dr. Zhang to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zhang is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Zhang's licenses on file in 3 states: New York, California and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Zhang treats.

CMS data shows 237,915 Medicare services from Dr. Zhang across 63 procedure codes in 2024, for 1,346 Medicare patients. Medicare paid $2,338,585 for them.

CMS counts 1,346 Medicare patients who saw Dr. Zhang in 2024. The largest group is 75 to 84, with 562 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 74, with 50% women.

In 2024, Dr. Zhang wrote 1,301 Medicare Part D claims for 208 patients. 71% of them were for generic drugs. CMS names the drug for 971 of them, across 29 drugs with 11 or more claims each, at $2,806,305 in total drug cost. In 2023, CMS named 622 claims across 25 drugs.

Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhang as offering telehealth.

Dmand AI links 30 papers to Dr. Zhang, published from 2015 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Depression, Emotions and Child Abuse. Dr. Zhang has published most often in J Community Support Oncol. Dr. Zhang's most frequent co-authors are Shazia Mahmud Hussain, MD, Abouelmagd Mohamed Makramalla, MD and Chirag M. Acharya, MD.

CMS Open Payments shows 48 general payments to Dr. Zhang from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,800.

Dr. Zhang graduated from Peking Union Medical College in 2008.

Dr. Zhang is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.